New England Journal of MedicineNEJMavacopanTavneosvasculitis
… Tavneos, to gain regulatory approval has been retracted by the New England Journal of Medicine (NEJM).1…
6articles mentioning institutions
6institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NEJM ×
NEJM
This institution is selected. Its supporting articles are shown below.
Articles mentioning NEJM
6 articles · page 1 of 1New England Journal of MedicineNEJMAHAAmerican Heart AssociationELVO
… decade and a half. In 2013, three trials were published in the New England Journal of Medicine (NEJM,) each demonstrating no benefit for MT for ELVO.1–3 These…
NEJMchronic lymphocytic leukemiahuCART19-IL18B-cell malignanciesnon-Hodgkin lymphomaNEJMoa2408771
…phoma and chronic lymphocytic leukemia, as recently reported in NEJM.1 These cohorts employed a 3-day manufacturing protocol—signifi…
79.5%
NEJMnivolumabA375 melanomasolitomabrelatlimab
…e data observed in the RELATIVITY-047 clinical trial (Tawbi H., NEJM, 2022). We also developed huPBMC mice that exhibit exclusively …
SciurbaFlynnNEJMMepolizumabchronic obstructive pulmonary diseaseCOPD-HELPinhaled corticosteroidsCOPDAECOPD
…ibody to interleukin-5, has been shown to reduce exacerbations (Sciurba, NEJM 2025) in people with chronic obstructive pulmonary diseas…
85.4%
Human Fertilisation and Embryology AuthorityNEJMpathogenic mtDNA variantsmitochondrial transplants
…In 2018 the Human Fertilisation and Embryology Authority gave permission for the first mitochondrial transplants to take…